Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974882 | PMC |
| http://dx.doi.org/10.1002/mdc3.13427 | DOI Listing |
Publication Analysis
Top Keywords
tremor/myoclonus syndrome
4
syndrome associated
4
associated thrombotic
4
thrombotic thrombocytopenic
4
thrombocytopenic purpura
4
purpura case
4
case report
4
report review
4
review literature
4
tremor/myoclonus
1
Similar Publications
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy.
Curr Opin Neurol
June 2019
Department of Oncology.
Purpose Of Review: Immune checkpoint inhibitors (ICPI) and chimeric antigen receptor T cells (CAR-T) represent novel therapies recently approved to treat a number of human cancers. As both approaches modulate the immune system, they can generate a number of immune-related adverse events (irAEs), including a large spectrum of novel neurological toxicities. These are of special interest given their potential severity and risk of compromising further oncologic treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!